⌘+K

Pulse Explore Communities Researchers Journals

Home Communities Explore

October 2, 2017Amyotrophic Lateral Sclerosis and Frontotemporal DegenerationOpen Access

July 2017 ENCALS statement on edaravone

Ammar Al‐Chalabi Peter M. Andersen Siddharthan Chandran Adriano Chiò Philippe Corcia Philippe Couratier Olof Danielsson Mamede de Carvalho Claude Desnuelle Torsten Grehl Julian Großkreutz Trygve Holmøy Caroline Ingre Merete Karlsborg Grethe Kleveland Jan Christoph Koch Blaž Koritnik Magdalena Kuźma‐Kozakiewicz Hannu Laaksovirta Albert C. Ludolph Christopher McDermott Thomas Meyer Bernardo Mitre Ropero Jesús Mora Pardina Ingela Nygren Susanne Petri Mónica Povedano Panadés François Salachas Pamela J. Shaw Vincenzo Silani Gert Staaf Kirsten Svenstrup Kevin Talbot Ole‐Bjørn Tysnes Philip Van Damme Anneke J. van der Kooi Markus Weber Patrick Weydt Joachim Wolf Orla Hardiman Leonard H. van den Berg

View Full Paper

Ask AI

Bookmark

Share

Abstract

Neurologists of the ENCALS centers throughout Europe have discussed the potential of edaravone as a new therapy for amyotrophic lateral sclerosis (ALS, Motor Neuron Disease, MND) at the ENCALS meet...

Discussion

No takes yet. Share an insight, caveat, or question.

Cite This Study

Al‐Chalabi et al. (2017) studied this question.

synapsesocial.com/papers/6ac59f710199ad4b0906419f https://doi.org/10.1080/21678421.2017.1369125

View Full Paper

Ask AI

Bookmark

Share

Keep reading

Synapse has enriched 5 related papers. Consider them for comparative context:

1End-of-life care of patients with amyotrophic lateral sclerosis and home mechanical ventilation: the national population-based DISCOVERY studyAmyotrophic Lateral Sclerosis and Frontotemporal Degeneration · Wed,
2Factors associated with post-tracheostomy survival in Amyotrophic Lateral SclerosisAmyotrophic Lateral Sclerosis and Frontotemporal Degeneration · Mon,
3Interventions to support informal carers managing behavioral symptoms in frontotemporal lobar degeneration: a scoping reviewAmyotrophic Lateral Sclerosis and Frontotemporal Degeneration · Thu,
4Mapping the evidence on dignity therapy in amyotrophic lateral sclerosis: a scoping reviewAmyotrophic Lateral Sclerosis and Frontotemporal Degeneration · Tue,
5Assessing the metabolic rate in patients with Amyotrophic Lateral Sclerosis, Progressive Muscular Atrophy, and Primary Lateral SclerosisAmyotrophic Lateral Sclerosis and Frontotemporal Degeneration · Mon,

More from Amyotrophic Lateral Sclerosis and Frontotemporal Degeneration

Specialist psychology provision for ALS/MND: results from a survey of UK ALS/MND servicesFri,
Harmonizing ALS research data across multimodal data sets using the OMOP Common Data ModelThu,
N-terminal proVGF modifications related to Amyotrophic Lateral SclerosisWed,
Clinical and genetic characterization of FUS -associated ALS in a tertiary cohortWed,
Assessing consciousness in end-stage ALS: response to young’s commentaryMon,